Molecular epidemiology of a citywide outbreak of extended-spectrum β-lactamase-Producing Klebsiella pneumoniae infection

Clinical Infectious Diseases

Volumn 35, Issue 7, 2002, Pages 834-841

  Quale, John M ^a,b   Landman, David ^a,b   Ravishankar, Jayshree ^a,b   Flores, Carlos ^a,b   Mayorga, David ^a,b   Vangala, Kalyani ^a,b   Adedeji, Adedeyo ^a,b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFEPIME; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; CLUSTER ANALYSIS; CORRELATION ANALYSIS; DISEASE TRANSMISSION; DNA FINGERPRINTING; GENETIC ANALYSIS; HOSPITAL INFECTION; KLEBSIELLA PNEUMONIAE; MULTIDRUG RESISTANCE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RIBOTYPING; UNITED STATES;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DISEASE OUTBREAKS; DNA, BACTERIAL; DRUG UTILIZATION; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; NEW YORK CITY; RIBOTYPING;

EID: 0036789271     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/342577     Document Type: Article

References (31)

1. Paterson DL, Mulazimoglu L, Casellas JM, et al. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum β-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis 2000; 30:473-8.
2. Intensive Care Antimicrobial Resistance Epidemiology (ICARE) surveillance report, data summary from January 1996 through December 1997. Am J Infect Control 1999; 27:279-84.
3. Wiener J, Quinn JP, Bradford PA, et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999; 281:517-23.
4. Saurina G, Quale JM, Manikal VM, Oydna E, Landman D. Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: epidemiology and relation to antibiotic usage patterns. J Antimicrob Chemother 2000; 45:895-8.
5. National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial susceptibility testing. 11th informational supplement. NCCLS document M100-S11. Wayne, PA: NCCLS, 2001.
6. Hollis RJ, Bruce JL, Fritschel SJ, Pfaller MA. Comparative evaluation of an automated ribotyping instrument versus pulsed-field gel electrophoresis for epidemiological investigation of clinical isolates of bacteria. Diagn Microbiol Infect Dis 1999; 34:263-8.
7. Matthew M, Harris AM. Identification of β-lactamases by analytical isoelectric focusing: correlation with bacterial taxonomy. J Gen Microbiol 1976; 94:55-67.
8. SHV genes. Antimicrob Agents Chemother 1999; 43:2960-3.
9. Bradford PA, Urban C, Mariano N, Projan SJ, Rahal JJ, Bush K. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrob Agents Chemother 1997; 41:563-9.
10. The Brooklyn Antibiotic Resistance Task Force. The cost of antibiotic resistance: effect of resistance among Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa on hospital length of stay. Infect Control Hosp Epidemiol 2002; 23:106-8.
11. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992-April 2000, issued June 2000. Am J Infect Control 2000; 28:429-48.
12. Winokur PL, Canton R, Casellas JM, Legakis N. Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis 2001; 32(Suppl 2):S94-103.
13. Cookson B, Johnson AP, Azadian B, et al. International inter- and intrahospital patient spread of a multiple antibiotic-resistant strain of Klebsiella pneumoniae. J Infect Dis 1995; 171:511-3.
14. Hobson RP, MacKenzie FM, Gould IM. An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampian region of Scotland. J Hosp Infect 1996; 33:249-62.
15. Monnet DL, Biddle JW, Edwards JR, et al. Evidence of interhospital transmission of extended-spectrum β-lactam-resistant Klebsiella pneumoniae in the United States, 1986-1993. Infect Control Hosp Epidemiol 1997; 18:492-8.
16. Arlet G, Rouveau M, Casin I, Bouvet PJM, Lagrange PH, Philippon A. Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 β-lactamase and which were isolated in 14 French hospitals. J Clin Microbiol 1994; 32:2553.
17. Quinn JP, Miyashiro D, Nathan C, Schiappa D, Weinstein R. Characterization of extended-spectrum β-lactamases among Klebsiella pneumoniae and E. coli strains from Chicago hospitals [abstract 322]. In: Program and abstracts of the 34th Annual Meeting of the Infectious Diseases Society of America (New Orleans), 1996. Clin Infect Dis 1996; 23:9
18. Coudron PE, Moland ES, Thomson KS. Occurrence and detection of AmpC β-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center. J Clin Microbiol 2000; 38:1791-6.
19. Cao VTB, Arlet G, Ericsson B, Tammelin A, Courvalin P, Lambert T. Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of plasmid-mediated CMY-4 and permeability alteration. J Antimicrob Chemother 2000; 46:895-900.
20. French GL, Shannon KP, Simmons N. Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and β-lactam-β-lactamase inhibitor combinations by hyperproduction of SHV-5 β-lactamase. J Clin Microbiol 1996; 34:358-63.
21. Martinez-Martinez L, Pascual A, Hernandez-Alles S, et al. Roles of β-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrob Agents Chemother 1999; 43:1669-73.
22. Rice LB, Carias LL, Hujer AM, et al. High-level expression of chromosomally encoded SHV-1 β-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae. Antimicrob Agents Chemother 2000; 44:362-7.
23. Girlich D, Karim A, Poirel L, Cavin M, Verny C, Nordmann P. Molecular epidemiology of an outbreak due to IRT-2 β-lactamase-producing strains of Klebsiella pneumoniae in a geriatric department. J Antimicrob Chemother 2000; 45:467-73.
24. Lemozy J, Sirot D, Chanal C, et al. First characterization of inhibitor-resistant TEM (IRT) β-lactamases in Klebsiella pneumoniae strains. Antimicrob Agents Chemother 1995; 39:2580-2.
25. Thomson KS, Moland ES. Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum β-lactamase-pro-ducing Enterobacteriaceae. Antimicrob Agents Chemother 2001; 45:3548-54.
26. Trick WE, Weinstein RA, DeMarais PL, et al. Colonization of skilled-care facility residents with antimicrobial-resistant pathogens. J Am Geriatr Soc 2001; 49:270-6.
27. Su LH, Leu HS, Chiu YP, et al. Molecular investigation of two clusters of hospital-acquired bacteraemia caused by multi-resistant Klebsiella pneumoniae using pulsed-field gel electrophoresis and infrequent restriction site PCR. J Hosp Infect 2000; 46:110-7.
28. Lucet J, Decre D, Fichelle A, et al. Control of a prolonged outbreak of extended-spectrum β-lactamase-producing enterobacteriaceae in a university hospital. Clin Infect Dis 1999; 29:1411-8.
29. Rahal JJ, Urban C, Horn D, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 1998; 280:1233-7.
30. Landman D, Chockalingham M, Quale JM. Reduction in the incidence of methicillin-resistant Staphylococcus aureus and Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clin Infect Dis 1999; 28:1062-6.
31. Rice LB, Eckstein EC, DeVente J, Shlaes DM. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 1996; 23:118-24.